Skip to main content

Advertisement

Table 2 Frequency of β1 integrin (β1), Progesterone Receptor (PR) and Estrogen Receptor (ER) expression in breast carcinomas

From: Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study

Markers Group P-value
   IDC DCIS  
   n (%) n (%)  
β1 Negative 151 (67,1) 45 (67,2) 1.000a
Positive 74 (32,9) 22 (32,8)  
PR Negative 87 (38,7) 20 (29,9) 0.198a
Positive 138 (61,3) 47 (70,1)  
ER Negative 76 (33,8) 17 (25,4) 0.233a
  Positive 149 (66,2) 50 (74,6)